Bioresorbable stents (BRS) were initially developed with the goal of providing adequate mechanical support and drug delivery in the short to medium term (one to two years) while gradually disappearing ...

Now, new research by the UK Dementia research Institute at the University of Cambridge has shown that a drug commonly used to treat glaucoma—an eye condition whereby the optic nerve becomes ...

ANGELA STENT is Professor Emerita at Georgetown University and a Nonresident Senior Fellow at the Brookings Institution. From 2004 to 2006, she served as National Intelligence Officer for Russia and ...

Eye floaters are not a sign of glaucoma, which typically causes gradual vision loss. Floaters are small dots or shapes that appear across a person’s vision. It is important to consult an eye ...

Additionally, the INFINITY-SWEDEHEART RCT data were published concurrently in The Lancet, in a peer-reviewed article entitled, “Bioadaptor implant versus contemporary drug-eluting stent in ...

Narrow angle glaucoma is a serious type of glaucoma that occurs when fluid cannot drain from the eye as it should, causing it to suddenly build up behind the iris. This causes a rapid, dangerous ...

XEN Aviation & Services Limited, a newly launched domestic airline operator based in Georgetown, has finalised a landmark deal to acquire its first Britten-Norman turbine-powered Islander aircraft.

The RESTO (Morphological Parameters of In‐Stent Restenosis Assessed and Identified by OCT [Optical Coherence Tomography]; study NCT04268875) was a prospective multicenter registry including patients ...

Approximately 4.22 million U.S. adults have glaucoma, with 1.49 million experiencing vision-impairing glaucoma, highlighting significant demographic variations. The study provides more comprehensive ...

The FDA has granted a de novo clearance to a new type of stent designed to hold open the passages down the windpipe and into the lungs, among patients that may have their airways pinched and ...